Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Adenomatous Polyposis Coli × Duration of Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 1 Osteoarthritis 1 Nausea 1 Cancer Pain 1 Breast Neoplasms 1 Adenomatous Polyposis Coli 1

Interventions

Erythromycin 2 rofecoxib 1 Duration of Therapy 1 Azithromycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00140894 2019-09-20

A Study of Rofecoxib in Familial Adenomatous Polyposis (FAP) (0966-205)(TERMINATED)

Merck Sharp & Dohme LLC

Phase 4 Terminated

Gastrointestinal

Cancer Pain, Osteoarthritis, Adenomatous Polyposis Coli

Data powered by HemOnc (CC BY 4.0) Colophon ⚡